Rejuvel Bio-Sciences, Inc. Stock

Equities

NUUU

US7594081074

Other Specialty Retailers

Delayed OTC Markets 15:57:48 2024-04-26 EDT 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Rejuvel Bio-Sciences, Inc. -.--% -.--%
Sales 2013 0.05 0.07 Sales 2014 0.09 0.13 Capitalization 35.47M 48.49M
Net income 2013 - 0 Net income 2014 - 0 EV / Sales 2013 * -
Net Debt 2013 508K 695K Net Debt 2014 388K 531K EV / Sales 2014 381,073,627 x
P/E ratio 2013 *
-
P/E ratio 2014
-190 x
Employees 1
Yield 2013 *
-
Yield 2014
-
Free-Float 31.84%
More Fundamentals * Assessed data
Dynamic Chart
Rejuvel Bio-Sciences, Inc. Announces Executive Appointments CI
Rejuvel Bio-Sciences, Inc. Announces Resignation of John T. Stickler, as Director and Officer CI
Rejuvel Bio-Sciences, Inc. announced that it has received $0.09 million in funding CI
Rejuvel Bio-Sciences, Inc. Announce the Completion of a Distribution Agreement with RJVL Ltd CI
Technology Applications International Corporation has Changed its Name to Rejuvel Bio-Sciences, Inc CI
Rejuvel Bio-Sciences, Inc. announced that it has received $0.11 million in funding from St. George Investments, LLC. CI
Rejuvel Bio-Sciences, Inc. Auditor Raises 'Going Concern' Doubt CI
Ron Levine Joins Technology Applications International Corporation's Advisory Board CI
Technology Applications International Corporation Appoints James Duddey to its Advisory Board CI
Technology Applications International Corporation Announces Clinical Studies Test for Efficacy in Transforming Ingredients for Affordable Skin Formulations CI
Technology Applications International Corporation announces an Equity Buyback. CI
Technology Applications International Corporation's Equity Buyback announced on August 28, 2014, has closed. CI
Technology Applications International Corporation authorizes a Buyback Plan. CI
Technology Applications International Corporation will Change its Ticker to NUUU from TCHA CI
Technology Applications International Corporation has completed an IPO in the amount of $3.00 million. CI
More news
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
2.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 79 09-10-13
Members of the board TitleAgeSince
Chief Executive Officer 79 09-10-13
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 26, 2024 at 03:57 pm

More quotes
Rejuvel Bio-Sciences, Inc., formerly Technology Applications International Corporation, is engaged in developing market entry technology products and services into early and mainstream technology products and services. The Company, through its subsidiaries, is focused on developing and manufacturing a line of technologically advanced skin care products and providing environmental management solutions that use electron particle accelerator technology. The Company offers REJUVEL 3D, which is ageless infinity microgravity cell renewal cream. REJUVEL 3D is a three-dimensional (3D) skin renewal system using National Aeronautics and Space Administration (NASA) technology. REJUVEL 3D has been formulated to address the skin care needs of both men and women of all skin types. The Company's subsidiaries include Rejuvel Int'l, Inc. and NueEarth, Inc.
More about the company